Teriparatide, bisphosphonates and HRT to osteoporosis of woman

被引:0
|
作者
Bazarra-Fernandez, A. [1 ]
Bazarra-Castro, M. A. [1 ]
机构
[1] Med Santiago Univ, Santiago, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:419 / 419
页数:1
相关论文
共 50 条
  • [1] Teriparatide and HRT against osteoporosis of woman
    Bazarra-Fernández, A
    BONE, 2006, 38 (03) : S7 - S7
  • [2] Teriparatide, HRT and osteoporosis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S127 - S127
  • [3] Teriparatide performance in osteoporosis of woman
    Bazarra-Fernandez, A.
    Bazarra-Castro, M. A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S25 - S25
  • [4] Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium
    Uebelhart, D
    Frey, D
    Frey-Rindova, P
    Goerres, G
    Michel, BA
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2003, 62 (06): : 512 - 517
  • [5] Continuous combined HRT and bisphosphonates in osteoporosis: Similarities and differences
    Kanis, JA
    BONE, 1996, 19 (05) : S177 - S177
  • [6] Prevention of osteoporosis with other than HRT-bisphosphonates
    Liberman, UA
    FIRST WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY, 1999, : 39 - 39
  • [7] Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis
    Yuan, Fei
    Peng, Wen
    Yang, Caihong
    Zheng, Jinping
    INTERNATIONAL JOURNAL OF SURGERY, 2019, 66 : 1 - 11
  • [8] Osteoporosebehandlung: Bisphosphonate, SERM’s, Teriparatide und StrontiumTherapy of osteoporosis: bisphosphonates, SERM’s, teriparatide and strontium
    D. Uebelhart
    D. Frey
    P. Frey-Rindova
    G. Goerres
    B. A. Michel
    Zeitschrift für Rheumatologie, 2003, 62 : 512 - 517
  • [9] The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis
    Ebina, Kosuke
    Hashimoto, Jun
    Kashii, Masafumi
    Hirao, Makoto
    Kaneshiro, Shoichi
    Noguchi, Takaaki
    Tsukamoto, Yasunori
    Yoshikawa, Hideki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2017, 35 (01) : 91 - 98
  • [10] Teriparatide versus bisphosphonates in high risk osteoporosis patients: A decision model analysis
    Hendley, YG
    DeLattre, ML
    Schaefer, MG
    Boggie, DT
    Tuey, C
    VALUE IN HEALTH, 2004, 7 (03) : 297 - 297